Source: Eur Respir J, 50 (3) 1700782; 10.1183/13993003.00782-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael A. Wortley, John J. Adcock, Eric D. Dubuis, Sarah A. Maher, Sara J. Bonvini, Isabelle Delescluse, Ross Kinloch, Gordon McMurray, Christelle Perros-Huguet, Marianthi Papakosta, Mark A. Birrell, Maria G. Belvisi. Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy. Eur Respir J, 50 (3) 1700782; 10.1183/13993003.00782-2017

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory and cytoprotective actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Late-breaking abstract: Cycloxygenase- and lypoxigenase-dependent generation of omega-3 electrophilic fatty acid-derivatives with anti-inflammatory properties Source: Annual Congress 2011 - Lung cell biology Year: 2011 Highly lipophilic fatty acid esters of the active metabolite of ciclesonide formed in vitro in rat lung tissue Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors in lipopolysaccharide-induced airway inflammation and tracheal hyperreactivity in mice Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Short-chain fatty acids are potent modulators of allergic airway inflammation Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006 The effects of erdosteine and caffeic acid phenethyl ester on the activities of some metabolic enzymes after cisplatin-induced nephrotoxicity in rats Source: Eur Respir J 2002; 20: Suppl. 38, 71s Year: 2002 Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 Ursodeoxy cholic acid (UDCA) reverses hepatotoxicity of multidrug treatment of mycobacterial infections Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018 Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis? Source: Eur Respir J 2009; 34: 145-155 Year: 2009 Targeting neuropeptide receptors by substance-P analogues identifies a strategy to develop novel anti-cancer therapies Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Safety and pharmacology of a soluble epoxide hydrolase inhibitor Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Free fatty acid receptors, FFAR1 and FFAR4, are novel bronchodilator targets in mouse and human precision-cut lung slices Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021 In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agent Source: Annual Congress 2010 - Models of airways disease Year: 2010 Is hyaluronic acid (HA) a marker of effectiveness of anti-inflammatory therapy in COPD patients? Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013